Pantoprazole
- TRADE NAMES: Protium (Nycomed); Protonix (Wyeth)
- INDICATIONS: Esophagitis associated with gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, erosive esophagitis
- CLASS: Proton pump inhibitor (PPI)
- HALF-LIFE: 1 hour
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, Allopurinol, Atazanavir, Cefditoren, Clopidogrel, Conivaptan, CYP2C19 inducers and substrates, Dabigatran, Dasatinib, Delavirdine, Dexmethylphenidate, Digoxin, Emtricitabine/Rilpivirine/Tenofovir Alafenamide, Erlotinib, Eucalyptus, Fluconazole, Indinavir, Iron salts, Itraconazole, Ketoconazole, Lapatinib, Letermovir, Mesalamine, Methotrexate, Methylphenidate, Mycophenolate, Nelfinavir, PEG-Interferon, Posaconazole, Raltegravir, Rilpivirine, Saquinavir, Tipranavir, Topotecan, Ulipristal, Voriconazole, Warfarin
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
